Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Dilutions for Hemiplegic Gait
NCT04630873Phase 1Recruiting
- Sponsor
- University of Ioannina
- Start
- Nov 2020
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of botulinum toxin type A in spastic hemiplegia (2 arms), sponsored by University of Ioannina. Primary endpoints: Change of Ankle motion at 1 month, Change of Modified Ashworth Scale at 1 month and 2 more. Started Nov 2020; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
spastic hemiplegia
Beyond the preview
Go deeper on NCT04630873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04630873.